Yaojuan Lu
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Rheumatology top 10%
- Osteoarthritis Treatment and Mechanisms
Papers in
-
- Bone Metabolism and Diseases 9
- TGF-β signaling in diseases 6
- RNA modifications and cancer 5
- Cancer-related gene regulation 4
- Oncology 12
- Cancer-related Molecular Pathways 7
- Co-authors
- Qiping Zheng (31 shared papers)Junxia Gu (26 shared papers)Longwei Qiao (16 shared papers)Feifei Li (4 shared papers)Lu Zhang (2 shared papers)Michael Sheldon (2 shared papers)Ping Zhang (3 shared papers)Xiaojun Xu (2 shared papers)
- Journals
- Gene (2 papers)Oncotarget (2 papers)Ceramics International (1 paper)Aging (1 paper)Journal of Cellular Physiology (1 paper)
- Partner nations
- ChinaUnited StatesTaiwan
In The Last Decade
Yaojuan Lu
41 papers receiving 887 citations
Peers
Comparison fields: 5 of 88
- Cancer Research 233
- Rheumatology 142
- Molecular Biology 537
- Oncology 213
- Immunology and Allergy 41
Countries citing papers authored by Yaojuan Lu
This map shows the geographic impact of Yaojuan Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yaojuan Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yaojuan Lu more than expected).
Fields of papers citing papers by Yaojuan Lu
This network shows the impact of papers produced by Yaojuan Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yaojuan Lu. The network helps show where Yaojuan Lu may publish in the future.
Co-authors
The 25 scholars most cited alongside Yaojuan Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 41 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 137 | |
| 2 | 2006 | 128 | |
| 3 | 2008 | 65 | |
| 4 | 2011 | 63 | |
| 5 | 2011 | 60 | |
| 6 | 2016 | 52 | |
| 7 | 2015 | 35 | |
| 8 | URI expression in cervical cancer cells is associated with higher invasion capacity and resistance to cisplatin. | 2015 | 26 |
| 9 | Expression analysis of URI/RMP gene in endometrioid adenocarcinoma by tissue microarray immunohistochemistry. | 2013 | 22 |
| 10 | Sequencing of short cfDNA fragments in NIPT improves fetal fraction with higher maternal BMI and early gestational age. | 2019 | 22 |
| 11 | Significant reduction in the LDL cholesterol increases the risk of intracerebral hemorrhage: a systematic review and meta-analysis of 33 randomized controlled trials. | 2020 | 19 |
| 12 | Endothelin-A receptor antagonists in prostate cancer treatment-a meta-analysis. | 2015 | 18 |
| 13 | Runx2 is required for activity of CD44+/CD24-/low breast cancer stem cell in breast cancer development. | 2020 | 17 |
| 14 | T-box family of transcription factor-TBX5, insights in development and disease. | 2017 | 16 |
| 15 | URI prevents potassium dichromate-induced oxidative stress and cell death in gastric cancer cells. | 2016 | 15 |
| 16 | Col10a1-Runx2 transgenic mice with delayed chondrocyte maturation are less susceptible to developing osteoarthritis. | 2014 | 15 |
| 17 | DLX5 promotes osteosarcoma progression via activation of the NOTCH signaling pathway. | 2021 | 13 |
| 18 | 2012 | 12 | |
| 19 | Upregulation of URI/RMP gene expression in cervical cancer by high-throughput tissue microarray analysis. | 2013 | 12 |
| 20 | 2014 | 11 |
About Yaojuan Lu
Yaojuan Lu is a scholar working on Molecular Biology, Oncology, Cancer Research, Rheumatology and Pharmacology, having authored 41 papers that have together received 893 indexed citations. Recurring topics across this work include Osteoarthritis Treatment and Mechanisms (10 papers), Bone Metabolism and Diseases (9 papers), Cancer-related Molecular Pathways (7 papers), TGF-β signaling in diseases (6 papers), RNA modifications and cancer (5 papers), Cancer-related molecular mechanisms research (5 papers), Cancer-related gene regulation (4 papers) and Inflammatory mediators and NSAID effects (4 papers). The work is most often cited by research in Cancer Research (233 citations), Rheumatology (142 citations), Molecular Biology (537 citations), Oncology (213 citations) and Immunology and Allergy (41 citations). Yaojuan Lu has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Qiping Zheng, Junxia Gu, Longwei Qiao, Feifei Li, Lu Zhang, Michael Sheldon, Ping Zhang, Xiaojun Xu, Caihong Sun and Ming Ding. Their work appears in journals such as Gene, Oncotarget, Ceramics International, Aging and Journal of Cellular Physiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.